Assembly Biosciences, Inc. (ASMB)
NASDAQ: ASMB · Real-Time Price · USD
13.00
+0.50 (4.00%)
At close: May 16, 2025, 4:00 PM
13.42
+0.42 (3.23%)
After-hours: May 16, 2025, 4:05 PM EDT
Assembly Biosciences Stock Forecast
Stock Price Forecast
According to 2 professional analysts, the 12-month price target for Assembly Biosciences stock ranges from a low of $31 to a high of $35. The average analyst price target of $33 forecasts a 153.85% increase in the stock price over the next year.
Price Target: $33.00 (+153.85%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 25, 2025.
Analyst Ratings
The average analyst rating for Assembly Biosciences stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Guggenheim | Guggenheim | Strong Buy Initiates $31 | Strong Buy | Initiates | $31 | +138.46% | Mar 25, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Mar 24, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Dec 27, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Sep 24, 2024 |
| Jefferies | Jefferies | Hold → Strong Buy Upgrades $2 → $35 | Hold → Strong Buy | Upgrades | $2 → $35 | +169.23% | Sep 20, 2024 |
Financial Forecast
Revenue This Year
31.61M
from 28.52M
Increased by 10.82%
Revenue Next Year
24.86M
from 31.61M
Decreased by -21.33%
EPS This Year
-5.79
from -6.69
EPS Next Year
-6.12
from -5.79
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 35.4M | 32.1M | 124.7M | ||
| Avg | 31.6M | 24.9M | 60.6M | ||
| Low | 27.7M | 17.8M | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 24.1% | 1.6% | 401.5% | ||
| Avg | 10.8% | -21.3% | 143.6% | ||
| Low | -2.9% | -43.6% | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -5.32 | -3.10 | 2.17 | ||
| Avg | -5.79 | -6.12 | -5.10 | ||
| Low | -6.16 | -8.87 | -11.83 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.